Elekta AB (OTCMKTS:EKTAY) Stock Short Interest Report for October

Elekta AB (OTCMKTS:EKTAY) was the target of a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 191 shares. Based on an average daily volume of 2,905 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are short sold.

Elekta Trading Up 0.2%

Shares of Elekta stock traded up $0.01 on Friday, hitting $5.92. 386 shares of the company traded hands, compared to its average volume of 851. The stock’s 50 day moving average price is $5.41 and its 200-day moving average price is $5.70. The company has a current ratio of 0.86, a quick ratio of 0.62 and a debt-to-equity ratio of 0.45. Elekta has a 52 week low of $4.35 and a 52 week high of $6.93. The company has a market cap of $2.18 billion, a PE ratio of -49.33 and a beta of 1.03.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings data on Thursday, August 27th. The company reported $0.07 earnings per share (EPS) for the quarter. The company had revenue of $372.30 million for the quarter. Elekta had a positive return on equity of 13.47% and a negative net margin of 2.38%. Equities research analysts predict that Elekta will post 0.43 EPS for the current year.

Analysts Set New Price Targets

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One research analyst has rated the stock with a Hold rating. According to MarketBeat.com, Elekta has a consensus rating of “Hold”.

Elekta Company Profile

Elekta AB is a Sweden-based medical technology company that develops and supplies systems and software for radiation therapy, radiosurgery and related cancer-care applications. Its solutions are designed to help hospitals and clinics treat tumors while supporting more precise, personalized and less invasive care.

The company’s portfolio includes linear accelerators, stereotactic radiosurgery systems, magnetic resonance-guided radiation therapy technology and brachytherapy products. Elekta also provides oncology information systems and workflow software, including platforms used for treatment planning, patient management and clinical data coordination.

Founded in 1972 by neurosurgeon and inventor Lars Leksell, Elekta initially focused on radiosurgery and later expanded into broader radiation oncology.